New Stocks and Investor Ideas in Biotech, Tech, Defense and Mining; (Nasdaq: ALPX) (Nasdaq: INTS) (NYSE: KEYS) (Nasdaq: BMR) (NYSE American: CTM) (CSE: GRCM)
Vancouver, Kelowna, Delta, BC - November 4, 2022 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Biotech, Tech, Defense and Mining. Today's stocks have been added to our lists of free stock directories in each sector.
The newest biotech companies are recent Nasdaq IPOS's, as are the new Tech and Defense companies.
The latest mining company is a recent CSE addition.
New Stocks added to the Biotech Stocks List:
Alopexx, Inc. (Nasdaq: ALPX) is a clinical stage biotechnology company targeting novel immune therapeutics for the prevention and treatment of bacterial, fungal and parasitic microbial infections. The target of our therapeutics, poly N-acetyl glucosamine (PNAG), has been found in a wide range of pathogens. Our vaccine candidate, AV0328, has been shown to induce protective antibodies against a wide range of PNAG-expressing pathogens in a Phase 1 trial. F598, our fully human monoclonal antibody, has been shown to be safe and well tolerated in phase 1 and pilot trials. Following a single infusion, it can provide protection for 2-3 months. Our goal is to develop a broad-spectrum, non-antibiotic therapeutic platform for the treatment and prevention of microbial infections. These immune therapeutics will reduce reliance on antibiotics and the development of antimicrobial resistance.
INTENSITY THERAPEUTICS, INC. (Nasdaq: INTS) is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. Intensity leverages its DfuseRx℠ technology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors. In addition to its clinical collaborations, the Company executed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's (NCI) Vaccine Branch in 2014.
New Stocks added to the Tech Stocks List:
Beamr Imaging Ltd. (Nasdaq: BMR) serves the world's top Pay TV and OTT video service providers as the leading designer and developer of content-adaptive encoding and optimization solutions that enable high quality, performance, and new levels of bitrate efficiency. Backed by 51 granted patents, and winner of the 2021 Technology and Engineering Emmy® award and the 2021 Seagate Lyve Innovator of the Year award, Beamr's perceptual optimization technology enables up to a 50% reduction in bitrate with guaranteed quality. Founded in 2009, Beamr maintains offices in Los Gatos, CA, Herzliya, Israel, and St. Petersburg, Russia.
Keysight Technologies, Inc. (NYSE: KEYS) delivers advanced design and validation solutions that help accelerate innovation to connect and secure the world. Keysight's dedication to speed and precision extends to software-driven insights and analytics that bring tomorrow's technology products to market faster across the development lifecycle, in design simulation, prototype validation, automated software testing, manufacturing analysis, and network performance optimization and visibility in enterprise, service provider and cloud environments. Our customers span the worldwide communications and industrial ecosystems, aerospace and defense, automotive, energy, semiconductor and general electronics markets. Keysight generated revenues of $4.9B in fiscal year 2021.
New Stocks added to the Defense Stocks List:
Castellum, Inc. (NYSE American: CTM) is a technology service and solutions company executing strategic acquisitions in Cyber Security, Information Technology, Information Warfare, Electronic Warfare, Systems Engineering, Software Engineering, and Software Development.
New Stocks added to the Mining Stocks List:
Geologica Resource Corp. (CSE:GRCM) is an exploration and development company focused on the acquisition, exploration and development of highly prospective North American mineral properties with the potential to develop world class deposits. With this in mind the company is engaged in the acquisition, exploration and development of high grade deposits of metals critical to the electrification of the planet and precious metals. Our exploration focus is currently to advance the Topley Project, located west of Smithers B.C. in the highly prospective Babine Lake area near the past producing Granisle and Bell copper mines. The Topley property is surrounded by operating mines and deposits.
The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.
About Investorideas.com - Big Investing Ideas
We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea's original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast, Cannabis News and Stocks on the Move Podcast, Cleantech and Climate Change Podcast, Exploring Mining Podcast, Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.
Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com
Learn more about advertising and guest posts
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
800 665 0411